Clinical Trial Results:
A DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, PLACEBO-CONTROLLED 10-WEEK STUDY ASSESSING THE EFFICACY AND SAFETY OF F2695 SR FLEXIBLE DOSE (75,100 MG /DAY) IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER
EFFICACY AND TOLERANCE OF F2695 SR IN MAJOR DEPRESSIVE DISORDER
Summary
|
|
EudraCT number |
2006-002404-34 |
Trial protocol |
EE DE FI CZ SE LV LT |
Global completion date |
22 Oct 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 Nov 2018
|
First version publication date |
21 Nov 2018
|
Other versions |
|
Summary report(s) |
final synopsis F2695 LP202 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.